PROS1 and viral infectious disease: Neither of the compounds inhibited control vesicle stomatitis virus (VSV) PsV virus infection (Supplementary Fig. S13), indicating that the inhibitory effects of CTSL inhibitors depend on SARS-CoV-2 S protein.